Chembio diagnostics, Inc.
CEMI
CEMI was delisted on the 27th of April, 2023.
76 hedge funds and large institutions have $23.7M invested in Chembio diagnostics, Inc. in 2020 Q2 according to their latest regulatory filings, with 48 funds opening new positions, 12 increasing their positions, 11 reducing their positions, and 14 closing their positions.
243% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 14
81% more funds holding
Funds holding: 42 → 76 (+34)
9% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 11
1% less call options, than puts
Call options by funds: $795K | Put options by funds: $803K
34% less capital invested
Capital invested by funds: $35.8M → $23.7M (-$12.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$8.84M |
| 2 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
+$5.41M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.93M |
| 4 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$2.61M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$11.2M |
| 2 |
RA
Royce & Associates
New York
|
-$5.61M |
| 3 |
AIC
AWM Investment Company
New York
|
-$2.69M |
| 4 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
-$2.18M |
| 5 |
AIP
ARS Investment Partners
New York
|
-$1.93M |
CEMI Hedge Fund Activity: Q2 2020 in Review
76 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Chembio diagnostics, Inc. (CEMI) for Q2 2020, worth a combined $23.7M — down 34% from $35.8M a quarter earlier.
Buyers outnumbered sellers: 48 funds opened new CEMI positions and 14 closed out — a net gain of 34 holders — while 12 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock, adding an estimated $8.84M. The largest seller was Nantahala Capital Management, cutting an estimated $11.2M.
- 76 institutional investors held Chembio diagnostics, Inc. (CEMI) as of Q2 2020, up from 42 in Q1 2020.
- Funds reported $23.7M of Chembio diagnostics, Inc. stock for Q2 2020, down 34% quarter-over-quarter.
- 48 funds opened new Chembio diagnostics, Inc. positions in Q2 2020 and 14 closed out, a net change of +34 holders.
- The largest Chembio diagnostics, Inc. buyer in Q2 2020 was BlackRock, an estimated $8.84M added.
- The largest Chembio diagnostics, Inc. seller in Q2 2020 was Nantahala Capital Management, an estimated $11.2M sold.
Based on aggregated 13F filings for Q2 2020.